Literature DB >> 7828718

Stimulation of transforming growth factor-beta 1 transcription by cyclosporine.

Y Prashar1, A Khanna, P Sehajpal, V K Sharma, M Suthanthiran.   

Abstract

In searching for a candidate mechanism for the immunosuppressive as well as fibrogenic consequences of cyclosporine usage, we have explored the hypothesis that cyclosporine stimulates transcription of transforming growth factor-beta 1 (TGF-beta 1), a multifunctional cytokine endowed with immunosuppressive and fibrogenic properties. Our results demonstrate that cyclosporine (i) stimulates TGF-beta 1 promoter-dependent transcription of chloramphenicol acetyl transferase gene in transiently transfected human A-549 cells, (ii) stimulates the synthesis of TGF-beta 1 RNA transcripts in human T cells, and (iii) permits the expression/emergence of DNA regulatory proteins (retinoblastoma control factor-1 (RCF-1) and RCF-2) that bind and regulate TGF-beta 1 promoter activity. Our studies demonstrate for the first time that cyclosporine stimulates TGF-beta 1 gene transcription and suggest a novel mechanism of action of cyclosporine.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7828718     DOI: 10.1016/0014-5793(94)01382-b

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  15 in total

Review 1.  [Rheumatology update. Current knowledge of etiology, pathophysiology, diagnosis, and therapy of selected arthritic disorders. Part I: pathogenesis and differential diagnosis].

Authors:  G Hein; P Oelzner; H Sprott; B Manger
Journal:  Med Klin (Munich)       Date:  1999-09-15

2.  CD28-B7-mediated T cell costimulation in chronic cardiac allograft rejection: differential role of B7-1 in initiation versus progression of graft arteriosclerosis.

Authors:  K S Kim; M D Denton; A Chandraker; A Knoflach; R Milord; A M Waaga; L A Turka; M E Russell; R Peach; M H Sayegh
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

Review 3.  The challenge of renal function in heart transplant children.

Authors:  Sylvie Di Filippo; Pierre Cochat; André Bozio
Journal:  Pediatr Nephrol       Date:  2006-08-24       Impact factor: 3.714

4.  Replicative senescence of biliary epithelial cells precedes bile duct loss in chronic liver allograft rejection: increased expression of p21(WAF1/Cip1) as a disease marker and the influence of immunosuppressive drugs.

Authors:  J G Lunz; S Contrucci; K Ruppert; N Murase; J J Fung; T E Starzl; A J Demetris
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

Review 5.  Allograft rejection and tubulointerstitial fibrosis in human kidney allografts: interrogation by urinary cell mRNA profiling.

Authors:  Thangamani Muthukumar; John R Lee; Darshana M Dadhania; Ruchuang Ding; Vijay K Sharma; Joseph E Schwartz; Manikkam Suthanthiran
Journal:  Transplant Rev (Orlando)       Date:  2014-05-27       Impact factor: 3.943

6.  Cyclosporin A inhibits colon cancer cell growth independently of the calcineurin pathway.

Authors:  Miriam B F Werneck; Eugênio Hottz; Patricia T Bozza; João P B Viola
Journal:  Cell Cycle       Date:  2012-09-19       Impact factor: 4.534

7.  Calcineurin inhibitors augment endothelial-to-mesenchymal transition by enhancing proliferation in association with cytokine-mediated activation.

Authors:  Craig B Woda; Sarah Bruneau; Anne Linde Mak; Zdenka Haskova; Kaifeng Liu; Chandra C Ghosh; David M Briscoe
Journal:  Biochem Biophys Res Commun       Date:  2019-09-18       Impact factor: 3.575

Review 8.  Kidney Fibrosis: Origins and Interventions.

Authors:  Thomas Vanhove; Roel Goldschmeding; Dirk Kuypers
Journal:  Transplantation       Date:  2017-04       Impact factor: 4.939

9.  Stimulation of the Ca2+-mediated egr-1 and c-fos expression in murine erythroleukaemia cells by cyclosporin A.

Authors:  A Schaefer; M Magócsi; A Fandrich; H Marquardt
Journal:  Biochem J       Date:  1998-11-01       Impact factor: 3.857

10.  DNA repair-deficient Xpa/p53 knockout mice are sensitive to the non-genotoxic carcinogen cyclosporine A: escape of initiated cells from immunosurveillance?

Authors:  Petra C E van Kesteren; Rudolf B Beems; Mirjam Luijten; Joke Robinson; Annemieke de Vries; Harry van Steeg
Journal:  Carcinogenesis       Date:  2009-01-09       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.